65 related articles for article (PubMed ID: 8691482)
1. A structure-activity relationship study of novel phenylacetamides which are sodium channel blockers.
Roufos I; Hays S; Schwarz RD
J Med Chem; 1996 Mar; 39(7):1514-20. PubMed ID: 8691482
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers.
Roufos I; Hays SJ; Dooley DJ; Schwarz RD; Campbell GW; Probert AW
J Med Chem; 1994 Jan; 37(2):268-74. PubMed ID: 8295214
[TBL] [Abstract][Full Text] [Related]
3. 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Liberatore AM; Schulz J; Pommier J; Barthelemy MA; Huchet M; Chabrier PE; Bigg D
Bioorg Med Chem Lett; 2004 Jul; 14(13):3521-3. PubMed ID: 15177465
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agents.
Reddy NL; Fan W; Magar SS; Perlman ME; Yost E; Zhang L; Berlove D; Fischer JB; Burke-Howie K; Wolcott T; Durant GJ
J Med Chem; 1998 Aug; 41(17):3298-302. PubMed ID: 9703475
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels.
Maillard MC; Perlman ME; Amitay O; Baxter D; Berlove D; Connaughton S; Fischer JB; Guo JQ; Hu LY; McBurney RN; Nagy PI; Subbarao K; Yost EA; Zhang L; Durant GJ
J Med Chem; 1998 Jul; 41(16):3048-61. PubMed ID: 9685245
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.
Ok D; Li C; Abbadie C; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Martin WJ; Priest BT; Smith MM; Williams BS; Wyvratt MJ; Parsons WH
Bioorg Med Chem Lett; 2006 Mar; 16(5):1358-61. PubMed ID: 16337121
[TBL] [Abstract][Full Text] [Related]
7. Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells.
Yanagita T; Maruta T; Uezono Y; Satoh S; Yoshikawa N; Nemoto T; Kobayashi H; Wada A
Neuropharmacology; 2007 Dec; 53(7):881-9. PubMed ID: 17950380
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.
De Luca A; Natuzzi F; Desaphy JF; Loni G; Lentini G; Franchini C; Tortorella V; Camerino DC
Mol Pharmacol; 2000 Feb; 57(2):268-77. PubMed ID: 10648636
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances in the structure-activity relationship study of small-molecule sodium channel blockers with analgesic effects].
Li W; Zhou Y; Liu HM; You QD
Yao Xue Xue Bao; 2009 Feb; 44(2):101-8. PubMed ID: 19408676
[TBL] [Abstract][Full Text] [Related]
10. Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamides.
Nanda KK; Nolt MB; Cato MJ; Kane SA; Kiss L; Spencer RH; Wang J; Lynch JJ; Regan CP; Stump GL; Li B; White R; Yeh S; Bogusky MJ; Bilodeau MT; Dinsmore CJ; Lindsley CW; Hartman GD; Wolkenberg SE; Trotter BW
Bioorg Med Chem Lett; 2006 Nov; 16(22):5897-901. PubMed ID: 16949818
[TBL] [Abstract][Full Text] [Related]
11. Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain.
Shao PP; Ye F; Weber AE; Li X; Lyons KA; Parsons WH; Garcia ML; Priest BT; Smith MM; Felix JP; Williams BS; Kaczorowski GJ; McGowan E; Abbadie C; Martin WJ; McMasters DR; Gao YD
Bioorg Med Chem Lett; 2009 Sep; 19(18):5334-8. PubMed ID: 19683443
[TBL] [Abstract][Full Text] [Related]
12. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
[TBL] [Abstract][Full Text] [Related]
13. Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides.
Cumming JG; Cooper AE; Grime K; Logan CJ; McLaughlin S; Oldfield J; Shaw JS; Tucker H; Winter J; Whittaker D
Bioorg Med Chem Lett; 2005 Nov; 15(22):5012-5. PubMed ID: 16154744
[TBL] [Abstract][Full Text] [Related]
14. Functional expression and purification of recombinant Tx1, a sodium channel blocker neurotoxin from the venom of the Brazilian "armed" spider, Phoneutria nigriventer.
Diniz MR; Theakston RD; Crampton JM; Nascimento Cordeiro Md; Pimenta AM; De Lima ME; Diniz CR
Protein Expr Purif; 2006 Nov; 50(1):18-24. PubMed ID: 16908187
[TBL] [Abstract][Full Text] [Related]
15. WIN 17317-3, a new high-affinity probe for voltage-gated sodium channels.
Wanner SG; Glossmann H; Knaus HG; Baker R; Parsons W; Rupprecht KM; Brochu R; Cohen CJ; Schmalhofer W; Smith M; Warren V; Garcia ML; Kaczorowski GJ
Biochemistry; 1999 Aug; 38(34):11137-46. PubMed ID: 10460170
[TBL] [Abstract][Full Text] [Related]
16. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
[TBL] [Abstract][Full Text] [Related]
17. 20(S)-protopanaxadiol and the ginsenoside Rh2 inhibit Na+ channel-activated depolarization and Na+ channel-dependent amino acid neurotransmitter release in synaptic fractions isolated from mammalian brain.
Duan Y; Nicholson RA
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Apr; 147(3):351-6. PubMed ID: 18262850
[TBL] [Abstract][Full Text] [Related]
18. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
[TBL] [Abstract][Full Text] [Related]
19. 2,4(5)-diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationships.
Fantini M; Rivara M; Zuliani V; Kalmar CL; Vacondio F; Silva C; Baheti AR; Singh N; Merrick EC; Katari RS; Cocconcelli G; Ghiron C; Patel MK
Bioorg Med Chem; 2009 May; 17(10):3642-8. PubMed ID: 19394229
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.
Hoyt SB; London C; Gorin D; Wyvratt MJ; Fisher MH; Abbadie C; Felix JP; Garcia ML; Li X; Lyons KA; McGowan E; MacIntyre DE; Martin WJ; Priest BT; Ritter A; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
Bioorg Med Chem Lett; 2007 Aug; 17(16):4630-4. PubMed ID: 17588748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
